Skip to main content

Neuronetics, Inc.

corporate_fare Company Profile

Neuronetics, Inc.

STIM·NASDAQ·Industrial Applications And Services·CIK 0001227636

Neuronetics, Inc. is a global neuroscience company focused on mental health, providing treatment options to patients and healthcare providers. The company's primary product is the NeuroStar Advanced Therapy System, a non-invasive, office-based treatment that uses transcranial magnetic stimulation (TMS). This system creates a pulsed, MRI-strength magnetic field to stimulate specific brain areas linked to mood. The NeuroStar Advanced Therapy System is cleared by the U.S. FDA to treat adult patients with major depressive disorder (MDD) who have not improved with prior antidepressant medication in their current MDD episode. It is also FDA-cleared as an adjunct for adults with obsessive-compulsive disorder (OCD) and for adolescent patients aged 15-21 with MDD. Additionally, it is FDA-cleared to reduce anxiety symptoms in adult MDD patients who also experience comorbid anxiety symptoms (anxious depression). Neuronetics sells the NeuroStar Advanced Therapy System and related treatment sessions. The company also operates Greenbrook treatment centers across the U.S., which are wholly owned subsidiaries offering NeuroStar Advanced Therapy. These centers also provide SPRAVATO® for adults with treatment-resistant depression or depressive symptoms in adults with MDD experiencing acute suicidal ideation or behavior. Neuronetics estimates that 237,574 global patients have been treated with over 8.5 million of their treatment sessions through December 31, 2025. For the year ended December 31, 2025, the company generated revenues of $149.2 million.

Neuronetics, Inc. (NASDAQ:STIM) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 38 items for STIM at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Neuronetics Sets Stage for Proxy Battle with Activist Investor, Proposes Dilutive Equity Plan
  • Activist Investor Jorey Chernett Demands Strategic Review, Sale of TMS Business
  • Neuronetics Initiates Up To 5% Workforce Reduction Amidst Financial Challenges
  • Neuronetics Announces CFO Departure, Workforce Reduction, and Reaffirms Guidance Amidst Activist Pressure
  • Largest Shareholder Calls for Neuronetics to Sell TMS Unit, Citing 5-7x Upside

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$149.16M
Net Income
-$39M
Diluted EPS
-$0.59
Op. Cash Flow
-$20.37M
Free Cash Flow
-$21.18M
Gross Profit
$72.31M
Operating Income
-$31.44M
Cash & Equivalents
$28.13M
Total Debt
$65.81M
Debt / Equity
2.94×
Net Margin
-26.1%
Shares Outstanding
68.99M sh
Source: 10-K · filed 2026-03-17 · accession 0001104659-26-029004
$1.25
52-week range · as of 2026-11-16 $0.80 – $3.44
Market cap
$97.16M
Volume
3M (1.2× avg)
3-mo avg 2.5M
Live data · 2026-11-22 12:47 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed STIM - Filings & News (Page 2)

STIM
Apr 09, 2026, 4:02 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $1.38
Real-time Price: $1.25 info
Change: -$0.1298 (-9%) info
Market Cap: $97.16M info
STIM
Apr 08, 2026, 9:17 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $1.66
Real-time Price: $1.25 info
Change: -$0.410 (-25%) info
Market Cap: $97.16M info
STIM
Apr 06, 2026, 4:51 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $1.88
Real-time Price: $1.25 info
Change: -$0.630 (-34%) info
Market Cap: $97.16M info
STIM
Apr 06, 2026, 4:40 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.93
Real-time Price: $1.25 info
Change: -$0.680 (-35%) info
Market Cap: $97.16M info
STIM
Apr 06, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $1.78
Real-time Price: $1.25 info
Change: -$0.530 (-30%) info
Market Cap: $97.16M info
STIM
Mar 31, 2026, 4:05 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $1.46
Real-time Price: $1.25 info
Change: -$0.210 (-14%) info
Market Cap: $97.16M info
STIM
Mar 30, 2026, 7:41 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $1.29
Real-time Price: $1.25 info
Change: -$0.0437 (-3%) info
Market Cap: $97.16M info
STIM
Mar 30, 2026, 9:37 AM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $1.27
Real-time Price: $1.25 info
Change: -$0.020 (-2%) info
Market Cap: $97.16M info
STIM
Mar 20, 2026, 8:51 AM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $1.47
Real-time Price: $1.25 info
Change: -$0.220 (-15%) info
Market Cap: $97.16M info
STIM
Mar 18, 2026, 10:36 AM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $1.22
Real-time Price: $1.25 info
Change: +$0.030 (+2%) info
Market Cap: $97.16M info
STIM
Mar 17, 2026, 4:54 PM EDT
Filing Type: S-3
Importance Score:
9
Price at Filing: $1.23
Real-time Price: $1.25 info
Change: +$0.020 (+2%) info
Market Cap: $97.16M info
STIM
Mar 17, 2026, 8:00 AM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $1.50
Real-time Price: $1.25 info
Change: -$0.2502 (-17%) info
Market Cap: $97.16M info
STIM
Mar 17, 2026, 7:55 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.49
Real-time Price: $1.25 info
Change: -$0.240 (-16%) info
Market Cap: $97.16M info
STIM
Mar 17, 2026, 7:50 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $1.50
Real-time Price: $1.25 info
Change: -$0.250 (-17%) info
Market Cap: $97.16M info
STIM
Mar 04, 2026, 5:33 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $1.35
Real-time Price: $1.25 info
Change: -$0.100 (-7%) info
Market Cap: $97.16M info
STIM
Mar 02, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.29
Real-time Price: $1.25 info
Change: -$0.040 (-3%) info
Market Cap: $97.16M info
STIM
Feb 10, 2026, 5:09 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.06
Real-time Price: $1.25 info
Change: -$0.810 (-39%) info
Market Cap: $97.16M info
STIM
Jan 06, 2026, 5:00 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.70
Real-time Price: $1.25 info
Change: -$0.450 (-26%) info
Market Cap: $97.16M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets